Pathologic fracture does not influence prognosis in stage IIB osteosarcoma: a case-control study.

Area of Science:

• Orthopedic Oncology
• Skeletal Tumors
• Cancer Prognosis

Background:

• Osteosarcoma is a primary bone malignancy often affecting young adults.
• Pathologic fractures can complicate osteosarcoma treatment and may influence prognosis.
• Stage IIB osteosarcoma indicates a locally advanced tumor requiring aggressive management.

Purpose of the Study:

• To evaluate the prognostic significance of pathologic fractures in patients with stage IIB osteosarcoma.
• To determine if pathologic fractures affect oncologic outcomes, including recurrence and survival.
• To assess the feasibility of limb salvage surgery in osteosarcoma with pathologic fractures.

Main Methods:

• Retrospective analysis of 15 patients with pathologic fractures and 50 controls with stage IIB osteosarcoma.
• Patients were matched for age, tumor site, and subtype.
• Treatment included immobilization, adjuvant chemotherapy, and limb salvage or amputation; functional outcomes (MSTS scores) were assessed.

Main Results:

• No significant differences in major complications between fracture (20.0%) and control (12.0%) groups.
• Local recurrence rates were similar: 26.7% in fracture group vs. 14.0% in control group.
• Overall 3-year survival (66.7% vs. 75.3%) and disease-free survival (53.3% vs. 66.5%) were not statistically different between groups.

Conclusions:

• Pathologic fracture is not a prognostic indicator for recurrence or survival in localized osteosarcoma.
• Limb salvage is achievable with adequate surgical margins and adjuvant chemotherapy.
• Effective management strategies can lead to favorable oncologic outcomes despite initial fracture.